These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

471 related articles for article (PubMed ID: 31826934)

  • 21. Agomelatine augmentation in obsessive compulsive disorder: a preliminary report.
    Tzavellas E; Karaiskos D; Ilias I; Liappas I; Paparrigopoulos T
    Psychiatriki; 2014; 25(3):179-84. PubMed ID: 25367661
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cognitive-behavioral therapy vs risperidone for augmenting serotonin reuptake inhibitors in obsessive-compulsive disorder: a randomized clinical trial.
    Simpson HB; Foa EB; Liebowitz MR; Huppert JD; Cahill S; Maher MJ; McLean CP; Bender J; Marcus SM; Williams MT; Weaver J; Vermes D; Van Meter PE; Rodriguez CI; Powers M; Pinto A; Imms P; Hahn CG; Campeas R
    JAMA Psychiatry; 2013 Nov; 70(11):1190-9. PubMed ID: 24026523
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatments used for obsessive-compulsive disorder-An international perspective.
    Brakoulias V; Starcevic V; Albert U; Arumugham SS; Bailey BE; Belloch A; Borda T; Dell'Osso L; Elias JA; Falkenstein MJ; Ferrao YA; Fontenelle LF; Jelinek L; Kalogeraki L; Kay B; Laurito LD; Lochner C; Maina G; Marazziti D; Martin A; Matsunaga H; Miguel EC; Morgado P; Mourikis I; Pasquini M; Perez Rivera R; Potluri S; Reddy JYC; Riemann BC; do Rosario MC; Shavitt RG; Stein DJ; Viswasam K; Wang Z; Fineberg NA
    Hum Psychopharmacol; 2019 Jan; 34(1):e2686. PubMed ID: 30628745
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Early onset of response with selective serotonin reuptake inhibitors in obsessive-compulsive disorder: a meta-analysis.
    Issari Y; Jakubovski E; Bartley CA; Pittenger C; Bloch MH
    J Clin Psychiatry; 2016 May; 77(5):e605-11. PubMed ID: 27249090
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An update on the pharmacological treatment of obsessive-compulsive disorder.
    Fontenelle LF; Nascimento AL; Mendlowicz MV; Shavitt RG; Versiani M
    Expert Opin Pharmacother; 2007 Apr; 8(5):563-83. PubMed ID: 17376013
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treating obsessive-compulsive disorder. Options include medication, psychotherapy, surgery, and deep brain stimulation.
    Harv Ment Health Lett; 2009 Mar; 25(9):4-5. PubMed ID: 19368037
    [No Abstract]   [Full Text] [Related]  

  • 27. Augmenting serotonin reuptake inhibitors in obsessive-compulsive disorder: What moderates improvement?
    Wheaton MG; Rosenfield D; Foa EB; Simpson HB
    J Consult Clin Psychol; 2015 Oct; 83(5):926-937. PubMed ID: 26009783
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Obsessive-compulsive disorder in schizophrenia: clinical characteristics and treatment.
    Poyurovsky M; Weizman A; Weizman R
    CNS Drugs; 2004; 18(14):989-1010. PubMed ID: 15584769
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Psychopharmacology of pediatric obsessive-compulsive disorder: three case reports.
    Oner O; Oner P
    J Psychopharmacol; 2008 Sep; 22(7):809-11. PubMed ID: 18308783
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacological treatment of childhood obsessive-compulsive disorder: from theory to practice.
    Grados MA; Riddle MA
    J Clin Child Psychol; 2001 Mar; 30(1):67-79. PubMed ID: 11294079
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New treatment models for compulsive disorders.
    Grant JE; Fineberg N; van Ameringen M; Cath D; Visser H; Carmi L; Pallanti S; Hollander E; van Balkom AJ
    Eur Neuropsychopharmacol; 2016 May; 26(5):877-84. PubMed ID: 26621260
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An overview of the pharmacological options for pediatric obsessive-compulsive disorder.
    Marazziti D; Pozza A
    Expert Opin Pharmacother; 2022 Nov; 23(16):1793-1800. PubMed ID: 36310087
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Obsessive compulsive disorder and the glutamatergic system.
    Kariuki-Nyuthe C; Gomez-Mancilla B; Stein DJ
    Curr Opin Psychiatry; 2014 Jan; 27(1):32-7. PubMed ID: 24270485
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical features of patients with obsessive-compulsive disorder showing different pharmacological responses].
    Sumitani S; Ueno S; Ishimoto Y; Taniguchi T; Tomotake M; Motoki I; Yamauchi K; Ohmori T
    Seishin Shinkeigaku Zasshi; 2006; 108(12):1282-92. PubMed ID: 17334085
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of compulsive hoarding.
    Saxena S; Maidment KM
    J Clin Psychol; 2004 Nov; 60(11):1143-54. PubMed ID: 15389621
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antipsychotic augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: a meta-analysis of double-blind, randomized, placebo-controlled trials.
    Dold M; Aigner M; Lanzenberger R; Kasper S
    Int J Neuropsychopharmacol; 2013 Apr; 16(3):557-74. PubMed ID: 22932229
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risperidone and haloperidol augmentation of serotonin reuptake inhibitors in refractory obsessive-compulsive disorder: a crossover study.
    Li X; May RS; Tolbert LC; Jackson WT; Flournoy JM; Baxter LR
    J Clin Psychiatry; 2005 Jun; 66(6):736-43. PubMed ID: 15960567
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Commonly asked questions in the treatment of obsessive-compulsive disorder.
    Arumugham SS; Reddy YC
    Expert Rev Neurother; 2014 Feb; 14(2):151-63. PubMed ID: 24372473
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A single-blinded case-control study of memantine in severe obsessive-compulsive disorder.
    Stewart SE; Jenike EA; Hezel DM; Stack DE; Dodman NH; Shuster L; Jenike MA
    J Clin Psychopharmacol; 2010 Feb; 30(1):34-9. PubMed ID: 20075645
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term outcome in adults with obsessive-compulsive disorder.
    Bloch MH; Green C; Kichuk SA; Dombrowski PA; Wasylink S; Billingslea E; Landeros-Weisenberger A; Kelmendi B; Goodman WK; Leckman JF; Coric V; Pittenger C
    Depress Anxiety; 2013 Aug; 30(8):716-22. PubMed ID: 23532944
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.